CCR2 and neoplasm: In the advanced stage of HCC, CCR2 inhibits anti-tumor immune responses by recruiting and activating immunosuppressive cells, such as the macrophages, myeloid-derived suppressor cells, and regulatory T cells, thereby promoting immune escape of HCC cells [51].